SOLID PHASE CROSSMATCH HELPS TO IDENTIFY FLOW CROSSMATCH POSITIVE PATIENTS AT MINIMAL RISK OF ANTIBODY MEDIATED GRAFT INJURY AFTER TRANSPLANTATION.

被引：0
|
作者：
Pelletier, Ronald [1 ]
Hadley, Gregg [1 ]
Rearick, Annette [1 ]
Adams, Patrick [1 ]
机构：
[1] Ohio State Univ, Med Ctr, Tissue Typing Lab, Columbus, OH 43210 USA
来源：
HUMAN IMMUNOLOGY | 2010年 / 71卷
关键词：
D O I：
10.1016/j.humimm.2010.06.091
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S47 / S47
页数：1
相关论文
共 15 条
  • [1] Solid Phase Crossmatch Help To Identify Flow Crossmatch Positive Patients at Minimal Risk for Transplantation
    Pelletier, R. P.
    Reariek, A.
    Hadley, G. A.
    Adams, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 290 - 291
  • [2] Antibody Mediated Rejection and Graft Survival in Deceased Donor Transplants with a Positive Flow Crossmatch.
    Labban, Barbara
    Ebcioglu, Zeynep
    Crew, R. John
    Vasilescu, E. Rodica
    Ratner, Lloyd E.
    Cohen, David J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 414 - 414
  • [3] Outcomes after Splenectomy for Severe Antibody Mediated Rejection in Positive Crossmatch Kidney Transplantation ( plus XMKTx)
    Chedid, M. F.
    Bentall, A. J.
    Gloor, J. M.
    Dean, P. G.
    Prieto, M.
    Stegall, M. D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 421 - 421
  • [4] A positive flow crossmatch pre transplant is associated with an increased risk of antibody mediated rejection if donor specific antibody is present.
    Campbell, PM
    Halpin, A
    Brinded, J
    Sutherland, M
    Enns, J
    Cockfield, S
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 158 - 158
  • [5] The Molecular Microscope Diagnostic System (MMDx) Fails to Detect Early Antibody Mediated Rejection after Flow Crossmatch Positive Pediatric Heart Transplantation
    Milligan, C.
    Singh, T.
    Nava, G.
    Kobayashi, R.
    Esteso, P.
    Daly, K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S475 - S476
  • [6] Thymoglobuline induction therapy creates excellent long-term outcome in patients with positive lymphocyte crossmatch after cardiac transplantation.
    Zuckermann, A
    Dunkler, D
    Haidbauer, B
    Muehlbauer, A
    Szent-Ivanyi, E
    Wolner, E
    Mayr, W
    Grimm, M
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 177 - 177
  • [7] ADDITION OF RITUXIMAB TO INDUCTION THERAPY DECREASES RISK OF ANTIBODY-MEDIATED REJECTION AND GRAFT LOSS IN RENAL TRANSPLANT RECIPIENTS WITH POSITIVE FLOW CROSSMATCH AND DONOR SPECIFIC ANTIBODIES
    Anwar, Siddiq
    Horwedel, Timothy
    Ashraf, Muhammad
    Khalid, Syed
    Brennan, Daniel
    Klein, Christina
    TRANSPLANT INTERNATIONAL, 2013, 26 : 79 - 79
  • [8] IS THERE AN INCREASED RISK TO GRAFT OUTCOME IN PATIENTS WITH PRETRANSPLANT FLOW B POSITIVE CROSSMATCHES THAT ARE NEGATIVE IN THE CLASS II DSA LUMINEX CROSSMATCH?
    Pelletier, Ronald P.
    Rearick, Annette
    Adams, Patrick W.
    HUMAN IMMUNOLOGY, 2008, 69 : S16 - S16
  • [9] Improved Graft Survival in Highly Sensitized Patients Undergoing Renal Transplantation After the Introduction of a Clinically Validated Flow Cytometry Crossmatch
    Limaye, Sandhya
    O'Kelly, Patrick
    Harmon, Grainne
    O'Neill, Derek
    Dorman, Anthony M.
    Walshe, Joseph
    Donohoe, John
    Little, Dilly
    Conlon, Peter J.
    Keogan, Mary T.
    TRANSPLANTATION, 2009, 87 (07) : 1052 - 1056
  • [10] Treatment and Pattern of Resolution of Antibody-Mediated Rejection with Hemodynamic Compromise Resistant to Standard Therapy after Heart Transplantation with a Positive Virtual Crossmatch
    Mokshagundam, D.
    Castleberry, C. D.
    Simpson, K. E.
    Ybarra, A. M.
    Scheel, J. N.
    Canter, C. E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S458 - S458
12